Shearman & Sterling advised Beijing Xinyu Meiye Holdings Limited as a selling shareholder in connection with the primary listing of Beauty Farm Medical and Health Industry Inc. on the Main Board of The Stock Exchange of Hong Kong Limited and its global offering. The initial public offering raised net proceeds of approximately HK$684.6 million.
Beauty Farm Medical and Health Industry Inc. is the largest provider of traditional beauty services and one of the major non-surgical aesthetic medical service providers in China. The company provides overall beauty and health management services, through its well-established and widely recognized brand portfolio of BeautyFarm, Palaispa, CellCare and Neology.
The Shearman & Sterling team below included trainee Michelle Chan (Hong Kong-Capital Markets).